ACCENDRA HEALTH INC/VA/ 8-K

What Happened
Accendra Health, Inc. announced on May 22, 2026 that it launched exchange offers and related consent solicitations for its outstanding 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030 (the “Old Notes”). In the Offers, the company is proposing to exchange the Old Notes for newly issued secured notes: 9.000% Senior Secured First Lien Notes due 2032 (First Lien Notes) and 9.750% Senior Secured Second Lien Notes due 2033 (Second Lien Notes). The company furnished a press release about the Offers (filed as Exhibit 99.1).

Key Details

• Filing date: May 22, 2026 (Form 8-K, Item 7.01 Regulation FD disclosure).
• Old Notes involved: 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030.
• New Notes offered: 9.000% Senior Secured First Lien Notes due 2032 and 9.750% Senior Secured Second Lien Notes due 2033.
• The First Lien Notes will be issued to holders who participate in the new-money issuance that accompanies the exchange offers; the Offers include both exchange offers and consent solicitations.

Why It Matters
This is a debt restructuring/financing move that affects the company’s capital structure and interest obligations. The higher coupon rates (9.000% and 9.750%) suggest the company is replacing lower-rate unsecured debt with higher-rate secured debt, which may increase interest expense but also gives new noteholders priority claims (first and second liens) over certain assets. Existing holders of the Old Notes must decide whether to tender into the Offers; shareholders and bond investors should watch how the transaction affects Accendra’s cash flow, credit profile, and future refinancing needs.